Table 2.
Total characteristics of therapy and prognosis
| Clinicopathological Factor | Number |
|---|---|
| Operation | 211 (100%) |
| Complete Surgical Staging | 114 (54.0%) |
| Maximal Resection | 97 (46.0%) |
| Residual Disease | |
| R0 | 142 (67.3%) |
| R1(< 1 cm) | 13 (6.2%) |
| 1–2 cm | 7 (3.32%) |
| > 2 cm | 8 (3.79%) |
| Record not found | 41 (19.4%) |
| Second Operation | 11 (5.25%) |
| Abdominal Dropsy | |
| 0 | 78 (37.0%) |
| < 500 ml | 81 (38.4%) |
| > 500 ml | 34 (16.1%) |
| Record not found | 18 (8.5%) |
| Lymph Nodes Excision (LMN) | 188 (89.1%) |
| No | 23 (10.9%) |
| Pelvic Region Only | 2 (0.9%) |
| Pelvic & Abdominal region | 186 (88.2%) |
| Surgery to Conserve Fertility | 8 (3.8%) |
| Chemotherapy Regimens | 177 (83.9%) |
| Platinum-based chemotherapy (PBC) | 174 (82.3%) |
| Platinum-free chemotherapy | 3 (1.4%) |
| TC | 150 (71.1%) |
| Others | 27 (13.0%) |
| FIGO stage | |
| I | 114 (54.0%) |
| II | 39 (18.5%) |
| III | 54 (25.6%) |
| IV | 4 (1.9%) |
| Chemotherapy Treatment Course | |
| < 6 | 39 (18.5%) |
| ≥ 6 | 138 (65.4%) |
| Death | 29 (13.7%) |
| Relapse | 48 (22.7%) |